OIMU
MDT icon

Osmosis Investment Management UK’s Medtronic MDT Stock Holding History

Osmosis Investment Management UK’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3M Sell
118,885
-154,746
-57% -$12.5M 0.43% 54
2026
Q1 		$23.9M Buy
273,631
+188,127
+220% +$18M 0.64% 31
2025
Q4 		$8.27M Buy
+85,504
New +$8.31M 0.21% 109

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Osmosis Investment Management UK's MDT Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Medtronic (MDT) stake by 57% in Q2 2026, selling an estimated $12.5M and leaving 118,885 shares worth $9.3M. The position accounts for 0.43% of the portfolio, ranked #54.

Osmosis Investment Management UK first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.9M in Q1 2026. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Osmosis Investment Management UK held 118,885 shares of Medtronic worth $9.3M as of Q2 2026.
  • Osmosis Investment Management UK sold 154,746 Medtronic shares in Q2 2026, an estimated $12.5M.
  • Medtronic made up 0.43% of Osmosis Investment Management UK's portfolio in Q2 2026, its #54 holding.
  • Osmosis Investment Management UK first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Medtronic position peaked at $23.9M in Q1 2026.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.